These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 38413593)
41. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. Pollard AJ; Launay O; Lelievre JD; Lacabaratz C; Grande S; Goldstein N; Robinson C; Gaddah A; Bockstal V; Wiedemann A; Leyssen M; Luhn K; Richert L; Bétard C; Gibani MM; Clutterbuck EA; Snape MD; Levy Y; Douoguih M; Thiebaut R; Lancet Infect Dis; 2021 Apr; 21(4):493-506. PubMed ID: 33217361 [TBL] [Abstract][Full Text] [Related]
42. A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques. Chen L; Ewing D; Subramanian H; Block K; Rayner J; Alterson KD; Sedegah M; Hayes C; Porter K; Raviprakash K J Virol; 2007 Nov; 81(21):11634-9. PubMed ID: 17715224 [TBL] [Abstract][Full Text] [Related]
43. Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis. Gardner CL; Burke CW; Tesfay MZ; Glass PJ; Klimstra WB; Ryman KD J Virol; 2008 Nov; 82(21):10634-46. PubMed ID: 18768986 [TBL] [Abstract][Full Text] [Related]
44. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles. Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098 [TBL] [Abstract][Full Text] [Related]
45. Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus. Atasheva S; Wang E; Adams AP; Plante KS; Ni S; Taylor K; Miller ME; Frolov I; Weaver SC Vaccine; 2009 Jul; 27(32):4309-19. PubMed ID: 19446595 [TBL] [Abstract][Full Text] [Related]
46. Eastern Equine Encephalitis Virus in the United States, 2003-2016. Lindsey NP; Staples JE; Fischer M Am J Trop Med Hyg; 2018 May; 98(5):1472-1477. PubMed ID: 29557336 [TBL] [Abstract][Full Text] [Related]
47. Type I interferon induction is correlated with attenuation of a South American eastern equine encephalitis virus strain in mice. Gardner CL; Yin J; Burke CW; Klimstra WB; Ryman KD Virology; 2009 Aug; 390(2):338-47. PubMed ID: 19539968 [TBL] [Abstract][Full Text] [Related]
50. Hypervariable Domain of Eastern Equine Encephalitis Virus nsP3 Redundantly Utilizes Multiple Cellular Proteins for Replication Complex Assembly. Frolov I; Kim DY; Akhrymuk M; Mobley JA; Frolova EI J Virol; 2017 Jul; 91(14):. PubMed ID: 28468889 [TBL] [Abstract][Full Text] [Related]
51. Common marmosets (Callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains. Adams AP; Aronson JF; Tardif SD; Patterson JL; Brasky KM; Geiger R; de la Garza M; Carrion R; Weaver SC J Virol; 2008 Sep; 82(18):9035-42. PubMed ID: 18614636 [TBL] [Abstract][Full Text] [Related]
52. Response to and efficacy of vaccination against eastern equine encephalomyelitis virus in emus. Tengelsen LA; Bowen RA; Royals MA; Campbell GL; Komar N; Craven RB J Am Vet Med Assoc; 2001 May; 218(9):1469-73. PubMed ID: 11345313 [TBL] [Abstract][Full Text] [Related]
53. CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice. Ma J; Wang H; Zheng X; Xue X; Wang B; Wu H; Zhang K; Fan S; Wang T; Li N; Zhao Y; Gao Y; Yang S; Xia X Int Immunopharmacol; 2014 Mar; 19(1):74-80. PubMed ID: 24440303 [TBL] [Abstract][Full Text] [Related]
54. Pathogenesis of aerosolized Eastern Equine Encephalitis virus infection in guinea pigs. Roy CJ; Reed DS; Wilhelmsen CL; Hartings J; Norris S; Steele KE Virol J; 2009 Oct; 6():170. PubMed ID: 19852817 [TBL] [Abstract][Full Text] [Related]
55. Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges). Dye JM; Warfield KL; Wells JB; Unfer RC; Shulenin S; Vu H; Nichols DK; Aman MJ; Bavari S Viruses; 2016 Apr; 8(4):94. PubMed ID: 27070636 [TBL] [Abstract][Full Text] [Related]